Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

710 to 734 of 919 results

AFK Sistema cleared to take over Russian drugmaker Veropharm

14-11-2012

Shares in Russian companies 36.6 and Veropharm surged in Monday afternoon trading on the Moscow Stock…

AFK SistemaGenericsMergers & AcquisitionsPharmaceuticalRegulationVeropharm

Myrexis board approves liquidation and dissolution plan

12-11-2012

US cancer and autoimmune diseases drug developer Myrexis (Nasdaq: MYRX) said on Friday that its board…

FinancialMergers & AcquisitionsMyrexisPharmaceutical

Sun Pharma to acquire DUSA Pharmaceuticals for $230 million

09-11-2012

India's Sun Pharmaceutical Industries (SUN.BO) has entered into a definitive agreement to acquire US…

DermatologicalsDUSA PharmaceuticalsLevulanMergers & AcquisitionsPharmaceuticalSun Pharmaceutical Industries

Immune Pharmaceuticals to acquire EpiCept under stock merger accord

08-11-2012

Privately-held Israeli company Immune Pharmaceuticals and US drug developer EpiCept Corp (Nasdaq: EPCT)…

EpiCeptImmune PharmaceuticalsInflammatory diseasesMergers & AcquisitionsOncologyPharmaceutical

Otsuka Pharma sets up joint venture in Turkey

07-11-2012

Otsuka Pharmaceutical (TYO: 4768), a mid-size Japanese drugmaker, and Abdi ����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������°brahim…

Abdi IbrahimEuropeMarkets & MarketingMergers & AcquisitionsOtsukaPharmaceutical

Another acquisition for Takeda, Envoy Therapeutics for up to $140 million

07-11-2012

Takeda Pharmaceutical (TYO: 4502), Japan's largest drugmaker, has clearly not quenched its thirst for…

Envoy TherapeuticsMergers & AcquisitionsNeurologicalPharmaceuticalTakeda Pharmaceuticals

Exonhit to acquire InGen BioSciences for 18 million euros

07-11-2012

French drug discovery and development firm Exonhit Therapeutics (ALEHT:FP) has entered into an agreement…

DiaxonhitExonhit TherapeuticsInGen BioSciencesMergers & AcquisitionsPharmaceutical

AFK Sistema may acquire Russian drugmaker Veropharm

06-11-2012

AFK Sistema, the financial conglomerate owned by the Russian billionaire Vladimir Yevtushenko, is considering…

AFK SistemaGenericsMergers & AcquisitionsPharmaceuticalVeropharm

Charles River Labs to buy majority stake in China's Vital River

31-10-2012

USA-based Charles River Laboratories International (NYSE:CRL) has entered into an agreement to acquire…

Asia-PacificCharles River LaboratoriesMergers & AcquisitionsPharmaceuticalVital River

Allergan 4th-qtr revenues up 6%; earnings exceed expectations

31-10-2012

US health care firm Allergan (NYSE: AGN) revealed yesterday that revenues for its fiscal fourth-quarter…

AllerganFinancialMergers & AcquisitionsPharmaceutical

Revised terms for ViiV Healthcare and Shionogi HIV partnership

30-10-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) says that Healthcare, its HIV/AIDS joint venture with Pfizer,…

Anti-viralsdolutegravirGlaxoSmithKlineMergers & AcquisitionsPfizerPharmaceuticalShionogiViiV Healthcare

Almirall expands in personalized medicine with 5% equity stake in AB-Biotics

24-10-2012

Spain's largest pharma company Almirall (ALM.MC) says it has reached an agreement with the Spanish biotech…

AB-BioticsAlmirallBiotechnologyMergers & AcquisitionsPharmaceuticalResearch

Pfizer to buy NextWave Pharma for as much as $680 million

23-10-2012

Global drugs behemoth Pfizer (NYSE: PFE) revealed yesterday that it is prepared to pay up to $680 million…

GenericsMergers & AcquisitionsNextWave PharmaceuticalsPfizerPharmaceuticalQuillivant

BioCryst and Presidio to merge, creating new competitor in HCV arena

22-10-2012

USA drugmaker BioCryst Pharmaceuticals (Nasdaq: BCRX) has signed a definitive accord to acquire privately…

Anti-viralsBioCryst PharmaceuticalsMergers & AcquisitionsPharmaceuticalPresidio Pharmaceuticals

India's Dr Reddy's to acquire OctoPlus for $35.7 million

22-10-2012

India's second largest drugmaker Dr Reddy's Laboratories (NYSE: RDY) announced this morning that it intendeds…

Dr Reddy's LaboratoriesGenericsMergers & AcquisitionsOctoPlusPharmaceutical

Alvogen to acquire majority stake in Kunwha Pharma; Alliance buys Opus

21-10-2012

Privately-held US drugmaker Alvogen last Friday entered into an agreement to acquire a majority share…

Alliance PharmaAlvogenGenericsKunwha PharmaMergers & AcquisitionsOpus GroupPharmaceutical

Pharmaceutical M&A activity declining slightly, reports Irving Levin Associates

21-10-2012

A new five-and-a-half year pharmaceutical merger and acquisition report published by Irving Levin Associates…

BiotechnologyMergers & AcquisitionsPharmaceutical

Mylan buys Indian production unit from SMS Pharma for $33 million

18-10-2012

Following speculation that started last month, India's SMS Pharmaceuticals this week confirmed that it…

Asia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesProductionSMS Pharmaceuticals

710 to 734 of 919 results

Back to top